Amphastar Pharmaceuticals, Inc. (AMPH)
27.55
-0.98
(-3.44%)
USD |
NASDAQ |
Feb 23, 16:00
27.51
-0.04
(-0.15%)
After-Hours: 19:59
Amphastar Pharmaceuticals SG&A Expense (Quarterly) : 50.97M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.132B |
| Pfizer Inc. | 4.162B |
| Organon & Co. | 433.00M |
| Catalyst Pharmaceuticals, Inc. | 42.21M |
| CorMedix, Inc. | 36.64M |